Apogee Therapeutics Inc (APGE) PT Lowered to $95 at Jefferies

February 2, 2026 7:41 AM EST Send to a Friend
Jefferies analyst Akash Tewari lowered the price target on Apogee Therapeutics Inc (NASDAQ: APGE) to $95.00 (from $98.00) while maintaining ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login